Certified by Founder Lodge
SR One Capital Management
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $200,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with who we believe to be top entrepreneurs, scientists and investment partners in an effort to
Company | Date | Round | Raised |
---|---|---|---|
ADARx Pharmaceuticals Inc. | August, 10 ,2023 | Series C | $200,000,000 |
Fore Biotherapeutics | August, 25 ,2023 | Series D | $75,000,000 |
Avalyn Pharma Inc. | September, 28 ,2023 | Series C | $175,000,000 |
Odyssey Therapeutics | December, 06 ,2023 | Series C | $101,000,000 |
Mission Therapeutics | March, 15 ,2024 | Unknown | $32,101,650 |